In another study, they suggest a novel categorization of the low‐grade and intermediate‐grade pancreatic neuroendocrine tumors based on the expression of Ki‐67 to predict recurrence after curative surgery. This evidence concerns the gene MKI67 and pancreatic neuroendocrine tumor.